Multilab-Logo, India
 New No.3, Appaiar Lane, Second Floor, Royapuram, Chennai - 600 013, Tamilnadu, India
 Email - 0, Phone - +9144 25984175,  Mobile - +91 94441 62346    
FAQ
Language    Search
  Cleanrooms Laboratory
  Pharmaceutical Testing



FAQ > Glossary of Terms > D Series > Double Blind Test
 

Cleanrooms Information

Pharmaceutical & Cleanroom Glossary of Terms

D5W(5 D/W), Dalton, Data Integrity, Data Migration, DDC(Direct Digital Control), D Value, Dead Leg, Decontamination, Deflagration, Degrading, Deionization, Deletion Map, De Minimis Release, Dementia, Demineralization, Denaturation, Dent, Depyrogenation, Desalination, Design Condition, Design Specification, Dessicant, Dessicators, Detonation, Deuteromycetes, DHL Vaccine, Diagnostic, Dialysis, Diatom, Diatomaceous Earth Diatomite(Kiselguhr(DE)), Diffusion, Digestion, Digital, Digital Certificate, Digital Representation, Digital Signature, Dilution, Dilution Factor, Diploid, Diplophase, Direct Impact System, Disaster, Discoloration(Welding), Disinfection, Dispensing, Dissimilation, Dissolved Solids, Distillation, DNA(Deoxyribonucleic Acid), DNAse(Deoxyribonuclease), DNA Arrary, DNA Replication, DNA Sequence, DNA Vector, Domain, Dominant Allele, DOP(Dioctyl Phthalate/Dispersed Oil Particulate), Dosage Form, Dosage Group, Double Blind Test, Drugs, Drug Product, Drug (Medicinal) Product, Durability, Dry Air, Dry Heat Sterilization, Dust, Dynamic Condition


Learn About Deadly Cancer Mesothelioma due to Asbestos Exposure, it can affect any one in the world

Double Blind Test
Used in Clinical Trials, this is a method to ensure that any one party cannot improperly influence the test. The product (either in a single strength dosage or in multiple dosages) and the placebo are packaged and given a code name known to only the initiating party. These are then sent to another party who gives the coded packages yet another code name or number, and makes a matrix of the previous name/number to the new name/number. This is then sent to the physician who administers these to the patient. At the end of the test, the physician provides records of which patient received which code name/number product. This is then cross-referenced to the intermediate matrix to determine the original code name/number. The results of the treatment are then correlated to determine the efficacy of the drug.
The structure of DNA as proposed by Watson and Crick. It consists of two right-handed helical polynucleotide chains coiled around the same axis. The two chains are anti-parallel with their 3rd to 5th internucleotide phosphodiester bonds running in opposite directions. Under most conditions, the coiling of the chains is such that if the ends are held still, as in circular DNA or in a large chromosome, the chains cannot be separated except by cleavage of one of the strands